AMIT PATEL
Medical Practice in Salt Lake City, UT

2013025, Sep 26, 2013

Sep 17, 2012

13/621702

Amit Patel - Salt Lake City UT, US
Annette M. Marleau - San Diego CA, US

Creative Medical Health, Inc. - Phoenix AZ

G01N 33/569

435 721, 435 39

Disclosed are tests, correlations and “theranostic” interventions aimed at optimizing general health through quantification of cells with regenerative potential in circulation. Some embodiments include use of circulating endothelial progenitor cell (EPC) testing as a means of quantifying general health status in a patient. The combination of EPC testing together with a naturopathic intervention, wherein the selection and dosage of said naturopathic intervention is tailored based on said quantitative test is provided. In other embodiments, regenerative cells are selected from the group comprising of very small embryonic like cells (VSEL), CD34 cells with hematopoietic potential, and circulating mesenchymal stem cells (MSC). Naturopathic interventions include recommendations of lifestyle modification, dietary supplements, intravenous vitamins, detoxification, acupuncture, and guided imagery.

2014002, Jan 23, 2014

Jul 1, 2013

13/932468

Francisco Javier Silva - Miramar FL, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US

A61K 35/12, G01N 33/50

424 937, 435378, 424574, 435 34, 435 71, 435 61, 435377

Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.

2014001, Jan 16, 2014

Jul 1, 2013

13/932562

Francisco Javier Silva - Miramar FL, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US

C12N 5/077

435377

Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.

2013027, Oct 17, 2013

Apr 17, 2013

13/865103

Vladimir Bogin - Portland OR, US
Amit Patel - Salt Lake City UT, US

Medistem, Inc. - San Diego CA

A61K 35/28

424 937

Disclosed are stem cells and nanoparticles derived from said stem cells, useful for the treatment of acute radiation syndrome (ARS) and other inflammatory conditions. In one embodiment, Endometrial Regenerative Cells (ERC) are administered to patients having been exposed to radiation to augment recovery of endogenous hematopoietic stem cells. In another embodiment, exosomes, nanoparticles that are generated by various stem cells are used as a drug for treatment of inflammatory conditions.

2013021, Aug 22, 2013

Dec 31, 2012

13/732204

Amit Patel - Salt Lake City UT, US

C12N 5/071, A61K 35/48

424 937, 435325, 435379, 424583, 514 2192

Various cells, stem cells, and stem cell components, including associated methods of generating and using such cells are provided. In one aspect, for example, an isolated cell that is capable of self-renewal and culture expansion and is obtained from a subepithelial layer of a mammalian umbilical cord tissue. Such an isolated cell expresses at least three cell markers selected from CD29, CD73, CD90, CD166, SSEA4, CD9, CD44, CD146, or CD105, and does not express at least three cell markers selected from CD45, CD34, CD14, CD79, CD106, CD86, CD80, CD19, CD117, Stro-1, or HLA-DR.

7963964, Jun 21, 2011

Apr 5, 2007

11/697034

Albert N. Santilli - Pepper Pike OH, US
Amit Patel - Salt Lake City UT, US

A61B 18/14

606 51, 606 52, 606205

A surgical clamp assembly includes a clamp having movable jaws, each of which has a clamping surface for engaging a portion of a patient's body. An electrode forms a portion of the clamping surface of at least one of the jaws, the electrode being capable of heating, severing, or cauterizing the portion of the patient's body that is grasped by the clamp. If desired, the clamp assembly can be provided with a retainer that prevents the jaws from being opened accidently. The clamp assembly also can include an actuator that can be detached from the clamp and removed from the operative site, leaving the locked clamp in place. In this type of assembly, when it is desired to remove the clamp, the actuator can be reattached to the clamp and used to disengage the toothed retainer, and thereafter can be used to spread the jaws in order to permit the clamp to be removed.

2013019, Aug 1, 2013

Jan 26, 2012

13/358797

Amit Patel - Salt Lake City UT, US

A61K 38/21, C12N 5/0775, C12N 5/0735, C12N 5/077, A61K 9/00, A61P 27/02, A61K 8/64, A61K 9/70, A61P 17/00, A61Q 19/00, A61P 17/02, A61P 11/00, C12N 5/071, A61K 9/127

424447, 435405, 435366, 424 852, 424400, 424450

The present disclosure is drawn to compositions and methods of making and using lyophilized platelet lysates. Specifically, a method of preparing a composition suitable for therapeutic use or as a culture medium can comprise steps of concentrating platelets from a platelet source to form a platelet rich portion of the platelet source, and lysing the platelets in the platelet rich portion to form a plurality of lysates. An additional step includes lyophilizing the lysates to form lyophilized platelet lysates in a composition with released concentrations of available growth factors, cytokines, and chemokines. In one example, at 30%, by platelet count, of platelets from a platelet source can be lysed using this process.